(VIANEWS) - Apache (APA), Pacira BioSciences (PCRX), Brunswick Corporation (BC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Apache (APA)
62.2% sales growth and 469.73% return on equity
Through its subsidiaries, APA Corporation explores for and develops oil and natural gas properties. The company has subsidiaries in Egypt, the United States and the United Kingdom. It also has offshore exploration operations. It also owns four Permian to Gulf Coast pipelines and operates processing, transmission, and gathering assets. APA Corporation was established in Houston, Texas in 1954.
Earnings Per Share
As for profitability, Apache has a trailing twelve months EPS of $-12.86.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 469.73%.Moving Average
Apache's worth is way higher than its 50-day moving average of $36.39 and way higher than its 200-day moving average of $36.81.Previous days news about Apache(APA)
- According to VentureBeat on Tuesday, 11 October, "Google, she said, is making it possible with developments such as Dataplex (which unifies distributed data and automates data management and governance) and support for unstructured data and Apache Spark on BigQuery."
- According to VentureBeat on Wednesday, 12 October, "Next, Google announced that its storage engine, BigLake, will support popular open-source table formats such as Apache Iceberg, Delta Lake and Apache Hudi. ", "With this integration, Google said, data practitioners will be able to create procedures in BigQuery, using Apache Spark, that integrate with their SQL pipelines."
2. Pacira BioSciences (PCRX)
37.1% sales growth and 5.65% return on equity
Pacira BioSciences, Inc. offers non-opioid pain relief and regenerative healthcare solutions to physicians and patients throughout the United States. EXPAREL is a bupivacaine injectable suspension. ZILRETTA is a triamcinolone-acetonide extended release injectable suspension. The company also offers iovera, which is a handheld non-opioid cryoanalgesia machine that delivers controlled amounts of cold temperature to specific nerves. The company also developed a proprietary multivesicular Liposome drug delivery system that allows drugs to be encapsulated without changing their molecular structures. Pacira Pharmaceuticals, Inc. was the company's former name. In April 2019, Pacira BioSciences, Inc. took over that title. Pacira BioSciences, Inc. is located in Tampa, Florida.
Earnings Per Share
As for profitability, Pacira BioSciences has a trailing twelve months EPS of $3.33.
PE Ratio
Pacira BioSciences has a trailing twelve months price to earnings ratio of 16.94. Meaning, the purchaser of the share is investing $16.94 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.65%.Yearly Top and Bottom Value
Pacira BioSciences's stock is valued at $56.31 at 01:23 EST, way under its 52-week high of $82.16 and way higher than its 52-week low of $45.05.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 14.3% and 34.7%, respectively.3. Brunswick Corporation (BC)
19.3% sales growth and 32.82% return on equity
Brunswick Corporation manufactures and markets recreational products around the world. The company operates in three segments: Propulsion, Parts & Accessories and Boat. It provides inboard and sterndrive outboard and inboard engine services to independent boat builders. This segment also works with marine distributors and specialty marine retailers. The Mercury Marine, Mercury MerCruiser Mariner, Mercury Racing and Mercury Diesel brands are available to this segment. Parts & Accessories provides parts, consumables and boat parts, electric products, motor oils, lubricants and marine electronic and control systems. It also supplies aftermarket retail, distributors and distribution companies with specialty vehicle and mobile products. The Mercury, Mercury Precision Parts and Quicksilver brands are all represented in this segment. Sea Ray sport boat and cruisers, Bayliner sport boats, runabouts, and Boston Whaler fiberglass off-shore boats, Lund fiberglass fishing vessels, Crestliner, Cypress Cay, Harris, Lowe, Lund, Lund aluminum fishing, utility, pontoon, deck, and dock boats, Heyday tow/wake aluminum boats, dealer and shared access club services for the marine industry via distributors and dealers. Brunswick Corporation was established in Mettawa in Illinois in 1845.
Earnings Per Share
As for profitability, Brunswick Corporation has a trailing twelve months EPS of $8.01.
PE Ratio
Brunswick Corporation has a trailing twelve months price to earnings ratio of 8.4. Meaning, the purchaser of the share is investing $8.4 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.82%.Earnings Before Interest, Taxes, Depreciation, and Amortization
Brunswick Corporation's EBITDA is 1.09.
Sales Growth
Brunswick Corporation's sales growth is 24.5% for the present quarter and 19.3% for the next.
4. First Bank (FRBA)
14% sales growth and 12.79% return on equity
First Bank offers a variety of banking services and products to businesses and individuals. It accepts deposits of all types, such as non-interest bearing demands deposits, interest bearing need accounts, money market accounts and savings accounts. Certificates of Deposit are also available. The company offers commercial and industrial loans as well as commercial real estate loans such owner-occupied, investor and construction loans and multi-family loans. Residential real estate loans include residential mortgages and first and second lien loans for home equity. Revolving credit lines are also available. Consumer and other loan options include personal and traditional installment loans. It also offers electronic banking services such as Internet and mobile banking and electronic bill payment. It had 18 branches that provided full service in Cinnaminson and Cranbury counties, Delanco and Denville counties, Ewing counties, Flemington counties, Flemington counties, Hamilton counties, Hamilton counties, Flemington counties, Flemington counties, Flemington counties, Flemington counties, Hamilton counties, Lawrence counties, Pennington and Randolph counties, New Jersey. Also, Doylestown and Trevose counties, Warminster and West Chester county in Pennsylvania. Hamilton is the headquarters of First Bank, which was established in 2007.
Earnings Per Share
As for profitability, First Bank has a trailing twelve months EPS of $1.3.
PE Ratio
First Bank has a trailing twelve months price to earnings ratio of 10.91. Meaning, the purchaser of the share is investing $10.91 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.79%.Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 10, 2022, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 1.59%.
Growth Estimates Quarters
The company's growth estimates for the present quarter and the next is 4.3% and 25%, respectively.5. AdaptHealth Corp. (AHCO)
10.4% sales growth and 6.91% return on equity
AdaptHealth Corp. and its subsidiaries provide home healthcare equipment and medical supplies in the United States. It provides equipment and services such as CPAP, bi-PAP, and home therapy supplies to people suffering from obstructive sleeping apnea. The company also offers oxygen therapy and home therapy to chronically ill patients who need it. The company serves Medicare beneficiaries, Medicaid and commercial payers. Plymouth Meeting is the headquarters of this company.
Earnings Per Share
As for profitability, AdaptHealth Corp. has a trailing twelve months EPS of $0.85.
PE Ratio
AdaptHealth Corp. has a trailing twelve months price to earnings ratio of 23.42. Meaning, the purchaser of the share is investing $23.42 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.91%.Revenue Growth
Year-on-year quarterly revenue growth grew by 17.9%, now sitting on 2.8B for the twelve trailing months.
Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is 55% and 117.6%, respectively.Yearly Top and Bottom Value
AdaptHealth Corp. 's stock is valued at $19.91 at 01:25 EST, way below its 52-week high of $28.75 and way above its 52-week low of $11.40.
Moving Average
AdaptHealth Corp. 's worth is below its 50-day moving average of $20.68 and higher than its 200-day moving average of $18.50.6. Hannon Armstrong Sustainable Infrastructure Capital (HASI)
7.7% sales growth and 5.96% return on equity
Hannon Armstrong Sustainable Infrastructure Capital, Inc. offers capital and services in support of the United States' energy efficiency, renewable energy, or other sustainable infrastructure markets. Projects of the company include projects to reduce energy consumption or costs in buildings and facilities. This includes solar energy, which can be used for heating, ventilation and air conditioning, lighting, energy controls and energy controls. The company also works in grid-connected projects which use cleaner energy sources such as solar or wind to produce power. It also invests in other infrastructure projects including upgrades to transmission and distribution systems and water and stormwater infrastructures. For U.S. income tax purposes, the company is a real property investment trust. If it pays at least 90% of its income tax to stockholders, the company would generally not be subject to federal corporate income tax. Hannon Armstrong Sustainable Infrastructure Capital, Inc., was established in 1981. It is located in Annapolis, Maryland.
Earnings Per Share
As for profitability, Hannon Armstrong Sustainable Infrastructure Capital has a trailing twelve months EPS of $1.
PE Ratio
Hannon Armstrong Sustainable Infrastructure Capital has a trailing twelve months price to earnings ratio of 29.3. Meaning, the purchaser of the share is investing $29.3 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.96%.7. Syneos Health (SYNH)
7% sales growth and 7.41% return on equity
Syneos Health, Inc. is a biopharmaceutical outsourcing company in North America, Europe, Africa, Asia-Pacific, Latin America, Europe, Middle East, Africa, Asia-Pacific, Asia-Pacific, Latin America, and Europe. The company operates in two distinct segments: Clinical Solutions and Commercial Solutions. Clinical Solutions provides services in developing diagnostics, drugs and biologics as well as digital therapeutics during clinical development. It is available from Phase I through IV. The segment offers individual services such as product development and regulatory consultancy, project management and protocol development. It also assists with clinical monitoring and technology-enabled patient engagement. Clinical home health and clinical trial diversity. Biometric and regulatory affairs services are provided. Commercial Solutions provides services for commercialization, which include deployment solutions and communications solutions such as advertising and public relations; and services in consulting to the healthcare, pharmaceutical and biotechnology industries. The original name of the company was INC Research Holdings, Inc., but it changed its name in January 2018 to Syneos Health, Inc. Syneos Health, Inc. is an American company that was founded in 2010. Its headquarters are in Morrisville, North Carolina.
Earnings Per Share
As for profitability, Syneos Health has a trailing twelve months EPS of $1.88.
PE Ratio
Syneos Health has a trailing twelve months price to earnings ratio of 25.33. Meaning, the purchaser of the share is investing $25.33 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.41%.